Thus, it is likely that the upregulation of HDAC6 is beneficial at the early stages of repair to promote cellular behavior, but it becomes contraindicative at later stages, when inflammation and fibrosis drive the transition to CKD. Here, HDAC6 is linked to chronic kidney disease.